Login
Toggle navigation
Videos
Categories
Trending
Renren Inc., China's biggest networking website by page views, is discussed by Yoshikami with Emily Chang and Cory Johnson on 'Bloomberg West'.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Joseph Chen and Chen Ji are the CEOs of Renren
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:00:00
Dr. Ian Walters, CEO, Portage Biotech Inc
00:10:00
Exploring Investment Opportunities in Digital Health: A Conversation with Babylon Health's CEO Ali Parsa
00:10:00
Ultra Lithium Reports Promising Drill Results and Eyes Strategic Partnerships
00:10:00
Exploring Lithium Investment Opportunities and Platforms
00:10:00
Osso CEO Eduardo Capelastegui highlights Neoenergia's key advancements in April, May, and June, focusing on...
00:10:00
Future of American Education: Increased School Time by 2030
00:10:00
Mark England Discusses Pressures Facing the Electricity and Gas Sectors | Marc England, CEO , Genesis Energy ltd.
00:10:00
Apex Gold: Unveiling Greenland's High-Grade Potential at One-to-One London Conference
00:10:00
Navigating Market Volatility: Insights on Timing and Trends
00:10:00
American West Metals Managing Director Dave O'Neill Discusses Key Developments at PDAC 2024 | Dave O'Neill, Managing Director, American West Metals Ltd.
00:10:00
Invests in healthcare and technology in the US and Europe|David Jegen,Managing Partner,F Prime Capital fka Fidelity Biosciences
00:10:00
ActivePort Group success has "far exceeded expectations" | Paul van Heerwaarden, Technical Operations Manager, ActiveOps PLCAOM:LSE